Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase 4 1Phase 2/3 1Phase 2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1

Interventions

Rituximab 8Cyclophosphamide 7Etoposide 5Prednisone 4Doxorubicin 4Vincristine 3Gemcitabine 3Bendamustine Hydrochloride 3prednylidene 2deltacortene 2Specimen Handling 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2CT-P10 2Busulfan 2venetoclax 1umbralisib 1ublituximab 1tebufenozide 1tafasitamab 1selinexor 1huachansu 1fludarabine phosphate 1epratuzumab 1cc-486 1Whole-Body Irradiation 1Vindesine 1VAP-cyclo protocol 1Thiotepa 1Tamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Lymphoma, Large B-Cell, Diffuse × VAP-cyclo protocol × Clear all
NCT00060385 2012-09-24

Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Terminated
3 enrolled
DermatologicLymphoidOther hematologic neoplasm

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡